<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Estimated glomerular filtration rate (eGFR) over time during follow-up in SPRINT participants with chronic kidney disease (CKD)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Estimated glomerular filtration rate (eGFR) over time during follow-up in SPRINT participants with chronic kidney disease (CKD)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Estimated glomerular filtration rate (eGFR) over time during follow-up in SPRINT participants with chronic kidney disease (CKD)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Two phases of eGFR changes during follow-up in the SPRINT participants with CKD. The rate of change in eGFR using the values at 6 months after randomization as the baseline was -0.47 mL/minute/1.73 m<sup>2</sup> per year in the intensive group (dashed line and triangles) and -0.32 mL/minute/1.73 m<sup>2</sup> per year in the standard group (solid line and circles). Open symbols denote fasting visits; closed symbols denote nonfasting visits.</div><div class="graphic_footnotes">SPRINT: Systolic Blood Pressure Intervention Trial.</div><div class="graphic_reference">Republished with permission of the American Society of Nephrology, from: Cheung AK, Rahman M, Reboussin DM, et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol 2017. Copyright © 2017; permission conveyed through Copyright Clearance Center, Inc.</div><div id="graphicVersion">Graphic 113666 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
